
    
      The primary endpoint was the evolution of time in range (TIR, 70-180 mg/dl) at 6 and 12
      months. Secondary endpoints included change in HbA1c, BMI, insulin doses, time below range
      (T<70 and T<54 mg/dl) and time above range (T>180 and T>250 mg/dl).

      Retrospective analysis Two-center study
    
  